Atlas Brown Inc. Has $795,000 Stock Position in Danaher Co. (NYSE:DHR)

Atlas Brown Inc. boosted its stake in shares of Danaher Co. (NYSE:DHR) by 3.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,463 shares of the conglomerate’s stock after purchasing an additional 123 shares during the quarter. Atlas Brown Inc.’s holdings in Danaher were worth $795,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Benjamin Edwards Inc. raised its position in Danaher by 1.8% in the 2nd quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock valued at $538,000 after buying an additional 38 shares during the last quarter. Wedge Capital Management L L P NC grew its stake in shares of Danaher by 3.2% during the 3rd quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 38 shares in the last quarter. Certified Advisory Corp raised its holdings in shares of Danaher by 4.5% in the second quarter. Certified Advisory Corp now owns 926 shares of the conglomerate’s stock valued at $231,000 after purchasing an additional 40 shares during the last quarter. Meridian Financial Partners LLC lifted its position in shares of Danaher by 4.4% in the third quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock worth $266,000 after purchasing an additional 40 shares in the last quarter. Finally, Kovack Advisors Inc. boosted its holdings in Danaher by 3.4% during the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after purchasing an additional 41 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Stephens reissued an “overweight” rating and set a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Raymond James lowered their target price on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Stifel Nicolaus lifted their price objective on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. Finally, Royal Bank of Canada reduced their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $286.80.

Danaher Price Performance

Shares of DHR stock traded down $3.32 during trading hours on Friday, reaching $234.77. The company’s stock had a trading volume of 2,135,630 shares, compared to its average volume of 2,710,872. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The firm’s 50 day simple moving average is $235.93 and its 200-day simple moving average is $253.88. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $169.57 billion, a price-to-earnings ratio of 44.80, a PEG ratio of 4.33 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s revenue was up 3.1% compared to the same quarter last year. During the same period last year, the firm posted $2.02 earnings per share. Sell-side analysts forecast that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.46%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.